Akihiro Usui

Dr. Akihiro Usui


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
KSKiyohiko Shuto
Kiyohiko Shuto
YNYoshihiro Nabeya
Yoshihiro Nabeya
MMMikito Mori
Mikito Mori
MYMasato Yamazaki
Masato Yamazaki
CKChihiro Kosugi
Chihiro Kosugi
KKKeiji Koda
Keiji Koda
Background: Postoperative changes in body composition (BC) have not been clearly defined. The aim of this study was to clarify the impact of postoperative comprehensive changes in BC on long-term prognosis in gastric cancer (GC) patients. Methods: A total of 366 GC patients who underwent radical gastrectomy were included. Postoperative changes in skeletal muscle volume, body fat volume, and skeletal muscle density were investigated at six months postoperatively using computed tomography and evaluated their association with long-term survival. Results: Patients with decreased muscle volume, decreased fat volume, and increased muscle density had a poor prognosis, respectively. When the risk scores based on these three BC parameters were applied, patients were classified from score 0 to 4, with survival rate declining as the scores improved: score 0, interim 5-year overall survival 94%; score 1, 82%; score 2, 73%; score 3, 56%; and score 4, 20%. BC change (score > 2) was an independent poor prognosticator (HR, 3.086; p < 0.001). Preoperative myosteatosis, high Charlson comorbidity, and total gastrectomy were identified as significant independent risk factors for BC change. Conclusions: Each of postoperative skeletal muscle loss, body fat loss, and muscle hyperdensity negatively affected prognosis of GC patients after surgery, and the BC risk scoring assessment well predicted the prognosis of postoperative patients with GC.

20 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KSKiyohiko Shuto
Kiyohiko Shuto
YNYoshihiro Nabeya
Yoshihiro Nabeya
MMMikito Mori
Mikito Mori
CKChihiro Kosugi
Chihiro Kosugi
AUAkihiro Usui
Akihiro Usui
HSHiroaki Shimizu
Hiroaki Shimizu
Background/Objectives: Myopenia, myosteatosis, and loss of body fat have been reported as adverse prognostic factors in various malignancies. However, the prognostic value of a composite evaluation of these body composition (BC) parameters remains unclear. The purpose of this study was to investigate the impact of preoperative BC status on postoperative outcomes in patients with esophageal cancer (EC). Methods: Seventy patients who underwent curative resection for thoracic EC were retrospectively analyzed. Psoas muscle area, psoas muscle density, and body fat area were measured on preoperative computed tomography. Using sex-adjusted cutoff values, each parameter was assigned a score of 1 if above the cutoff or 0 if below, yielding a composite BC score ranging from 0 to 3. Associations with 5-year overall survival (5y-OS) and postoperative complications were assessed. Results: Low muscle mass, reduced muscle density, and low body fat were each associated with poorer survival, with hazard ratios (HRs) of 2.900, 2.909, and 2.990, respectively (p = 0.005, 0.028, and 0.002). Patients with unfavorable BC (score ≤1) showed significantly worse 5y-OS (25% vs. 72%, p < 0.001) and a higher incidence of postoperative severe complications (42% vs. 18%, p = 0.028). On multivariate analysis, BC status was identified as an independent prognostic factor (HR = 3.940, p = 0.002), comparable to pathological stage (HR = 6.028, p = 0.005). Conclusions: A composite BC status incorporating skeletal muscle mass, muscle density, and body fat serves as a valuable predictor of short- and long-term outcomes in postoperative EC patients, providing an integrated measure of patient vulnerability.

13 September 2024 in Cancers
Verified
Journal Article
Open access
PDF file
TMTakashi Murakami
Takashi Murakami
HSHiroaki Shimizu
Hiroaki Shimizu
HNHiroyuki Nojima
Hiroyuki Nojima
KSKiyohiko Shuto
Kiyohiko Shuto
AUAkihiro Usui
Akihiro Usui
KKKeiji Koda
Keiji Koda
Objective: The diagnostic efficacy of the apparent diffusion coefficient (ADC) in diffusion-weighted magnetic resonance imaging (DW-MRI) for lymph node metastasis in biliary tract cancer was investigated in the present study. Methods: In total, 112 surgically resected lymph nodes from 35 biliary tract cancer patients were examined in this study. The mean and minimum ADC values of the lymph nodes as well as the long-axis and short-axis diameters of the lymph nodes were assessed by computed tomography (CT). The relationship between these parameters and the presence of histological lymph node metastasis was evaluated. Results: Histological lymph node metastasis was detected in 31 (27.7%) out of 112 lymph nodes. Metastatic lymph nodes had a significantly larger short-axis diameter compared with non-metastatic lymph nodes (p = 0.002), but the long-axis diameter was not significantly different between metastatic and non-metastatic lymph nodes. The mean and minimum ADC values for metastatic lymph nodes were significantly reduced compared with those for non-metastatic lymph nodes (p < 0.001 for both). However, the minimum ADC value showed the highest accuracy for the diagnosis of histological lymph node metastasis, with an area under the curve of 0.877, sensitivity of 87.1%, specificity of 82.7%, and accuracy of 83.9%. Conclusions: The minimum ADC value in DW-MRI is highly effective for the diagnosis of lymph node metastasis in biliary tract cancer. Accurate preoperative diagnosis of lymph node metastasis in biliary tract cancer should enable the establishment of more appropriate treatment strategies.

25 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
TMTakashi Murakami
Takashi Murakami
HSHiroaki Shimizu
Hiroaki Shimizu
HNHiroyuki Nojima
Hiroyuki Nojima
KSKiyohiko Shuto
Kiyohiko Shuto
AUAkihiro Usui
Akihiro Usui
KKKeiji Koda
Keiji Koda
Objective: The diagnostic efficacy of the apparent diffusion coefficient (ADC) on diffusion-weighted magnetic resonance imaging for lymph node metastasis in biliary tract cancer was investigated in the present study. Methods: Surgically resected 112 lymph nodes from 35 biliary tract cancer (BTC) patients were examined in this study. Values of the ADC mean and minimum of lymph nodes, as well as short-axis and long-axis diameters of lymph nodes were assessed by computed tomography (CT). The relationship between these parameters and the presence of histological lymph node metastasis was evaluated. Results: Histological lymph node metastasis was detected in 31 (27.7%) out of 112 lymph nodes. The short-axis diameter in metastatic lymph nodes was significantly larger than that in non-metastatic lymph nodes (P = 0.002), but the long-axis diameter was not significantly different between metastatic and non-metastatic lymph nodes. Both ADC mean and minimum values in metastatic lymph nodes were significantly lower than those in non-metastatic lymph nodes (P < 0.001, respectively). However, the ADC minimum value showed the highest accuracy for the diagnosis of histological lymph node metastasis, with an area under the curve of 0.877, sensitivity of 87.1%, specificity of 82.7%, and accuracy of 83.9%. Conclusions: The ADC minimum value on diffusion-weighted magnetic resonance imaging was very useful for the diagnosis of lymph node metastasis in BTC.